EQS-Adhoc: Cytos Biotechnology AG: Novartis buys out CAD 106 license agreement for CHF 4 million
EQS Group-Ad-hoc: Cytos Biotechnology AG / Key word(s): Agreement Cytos Biotechnology AG: Novartis buys out CAD 106 license agreement for CHF 4 million 25.03.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 336909 25.03.2015 ...